• -
254 Results
Medical law
Promoted Yet Unproven: How State Laws Expand Access to Unchecked Stem Cell Interventions
The safety and efficacy of many stem cell treatments remain unproven by the FDA, yet state laws promote access and use of these unchecked and potentially harmful treatments. Fellow Kirstin R.W. Matthews summarizes her recent publication in a new commentary — outlining public health consequences of these state laws and calling for scientific societies’ advocacy in state policymaking.
Kirstin R.W. Matthews May 13, 2024
electric vehicle factory
How the US-China Trade War and the Inflation Reduction Act Could Shape Mexico’s Nearshoring Future
Amid U.S. efforts to strengthen supply chains and counterbalance China’s growing influence, Mexico is poised to benefit from “nearshoring,” writes scholar Adrian Duhalt. This brief explores how the Inflation Reduction Act and rising trade tensions between the U.S. and China could help Mexico secure its top trading position with the U.S. for years to come.
Adrian Duhalt April 23, 2024
Carbon+Nanotubes
Balancing Safety and Innovation: Shaping Responsible Carbon Nanotube Policy
Qualities like amazing tensile strength and electrical conductivity offer a huge range of uses for carbon nanotubes. In a new policy brief, fellow Rachel A. Meidl and her co-authors Dana Goerzen and Daniel A. Heller explain that to ensure carbon nanotubes’ role in a circular, sustainable economy, a coordinated system for classifying, testing, and identifying CNTs and a life cycle approach to risk assessments are needed to better understand impacts to facilitate consistent communication among researchers, industries, and policymakers.
Dana Goerzen, Daniel A. Heller, Rachel A. Meidl February 28, 2024